Asia Pacific Fill Finish Manufacturing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Consumables and Instruments) and End User (Contract Manufacturing Organizations, Biopharmaceutical Companies, and Other End Users)
Market Introduction
Asia Pacific includes countries such as China, Japan, India, Australia, and South Korea. Japan held the largest share in the market Japan is the third-largest pharmaceutical market in the world. Developing a new biopharmaceutical drug product for the Japanese market is a leading business priority for pharmaceutical companies while aligning with ethical drivers to treat more patients genuinely needy. Hence, the robust production of pharmaceutical drugs and export is done by the market players. Many market players are receiving approvals for the new products. For instance, In April 2020, ReForm Biologics Announced the Issuance of U.S. and Japanese Patents for Therapeutic Protein Formulations. Thus, increasing the production of biologics in Japan. Additionally, the market players are adopting organic and inorganic growth strategies for market development. In September 2018, Dalton Pharma Services announced the addition of an automated sterile liquid filling to its manufacturing capacity. Headquartered in Toronto, Canada, Dalton is contract research, development, and manufacturing organization (RDMO). The company said the investment is part of a US$10m facility and capital expansion.
The Asia Pacific biopharmaceutical industry has been disturbed for few months of 2020 during the outbreak of the COVID-19 pandemic. However, with the rising demand for products to treat the COVID-19 infection, the biopharmaceutical and pharmaceutical companies in the countries such as India and China have increased their production of APIs as the countries are the largest exporters to western companies. For instance, Wockhardt Ltd is in talks with the Indian government to offer its fill-finish capacity for the covid-19 vaccines that will be developed in the country, as well as with some firms whose vaccines are currently in phase I/II trials globally. Moreover, on 07 May 2020, Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services with sites in Belgium, United States, Japan, and India, announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late-stage biotechnology company, for the supply of the investigational new drug, leronlimab (PRO 140), which is currently being used in clinical trial protocols for Mild-to-Moderately Ill and Severely Ill COVID-19 patients.
Get more information on this report :
Market Overview and Dynamics
The fill finish manufacturing market in Asia Pacific is expected to grow from US$ 1,757.71 million in 2020 to US$ 3,489.39 million by 2027; it is estimated to grow at a CAGR of 10.3% from 2020 to 2027. Parenteral administration is one of the most prominent routes chosen to stimulate immediate immune response and ensure 100% bioavailability of pharmaceutical products. A steady rise in the development and market availability of parenteral drugs has propelled the demand for advanced, cost-effective drug delivery devices that promise ease of administration. Prefilled syringes segment is a rapidly growing segment of the fill-finish manufacturing market. The benefits of prefilled syringes over traditional delivery systems include easy administration, improved safety, accurate dosing, and reduced contamination risks, among others. Among drug delivery devices, prefilled syringes represent one of the fastest-growing primary packaging formats, which are also designed for dose administration. In the past 10 years, there has been an evident increase in the development of parenteral drugs (especially with the introduction of several classes of biologics), which has resulted in approximately three-fold increase in the consumption of prefilled syringes. The sustained preference for the pre-filled syringes can be attributed to safety and easy-of-use of these products. Current variants are designed with provisions to reduce errors in dosing, risk of occlusions, leakage of fluids (i.e., extravasation), and inflammation of veins (phlebitis). Owing to the benefits mentioned above, several injectable drugs— Humira, Enbrel, Avastin, PREVNAR 13, ALPROLIX, and Benefix, among others—diluents, and other products requiring parenteral administration are packaged in prefilled syringes. Over the past seven years, ~90 drugs have been approved in the prefilled syringe packaging form across different geographies. Several drugs in clinical stages of drug development are being evaluated in combination with prefilled syringes. The filling of sterile drugs into prefilled syringes is considered one of the most crucial steps in the pharmaceutical production process. Proper fill finish operations are necessarily carried out under aseptic conditions to maintain pharmacological efficacy and quality and to ensure the safety of end users. The prefilled syringe filling is a complex operation as it requires close monitoring of both the syringe fill volume and the headspace between liquid in the syringe and bottom of the plunger. Additionally, the rise in complexity of small molecule APIs and the increasing diversity of biologic drugs also contribute to the demand for advanced aseptic fill finish operation.
Key Market Segments
In terms of product, the consumables segment accounted for the largest share of the Asia Pacific fill finish manufacturing market in 2019. Further, in term of consumables, the prefilled syringes segment held a larger market share in 2019. Similarly, based on end user, the contract manufacturing organizations segment held a larger market share of the fill finish manufacturing market in 2019.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the fill finish manufacturing market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BD; West Pharmaceutical Services, Inc.; Gerresheimer AG; I.M.A. Industria Macchine Automatiche S.P.A.; Bausch+Strobel; Groninger and Co. GmbH; Maquinaria Industrial Dara SL; Nipro PharmaPackaging; SCHOTT AG; SGD Pharma; Stevanato Group; Syntegon Technology GmbH; and Optima Packaging Group Gmbh among others.
Reasons to buy report
- To understand the Asia Pacific fill finish manufacturing market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific fill finish manufacturing market
- Efficiently plan M&A and partnership deals in Asia Pacific fill finish manufacturing market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific fill finish manufacturing market
- Obtain market revenue forecast for market by various segments from 2020-2027 in Asia Pacific region.
Asia Pacific Fill Finish Manufacturing Market Segmentation
Asia Pacific Fill Finish Manufacturing Market – By Product
- Consumables
- Prefilled Syringes
- Vials
- Cartridges
- Other Consumables
- Instruments
Asia Pacific Fill Finish Manufacturing Market – By End User
- Contract Manufacturing Organizations
- Biopharmaceutical Companies
- Other End Users
Asia Pacific Fill Finish Manufacturing Market – By Country
- Japan
- China
- India
- South Korea
- Australia
- Rest of Asia Pacific
Asia Pacific Fill Finish Manufacturing Market – Companies Mentioned
- Becton, Dickinson and Company (BD)
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
- I.M.A. Industria Macchine Automatiche S.P.A.
- Bausch+Strobel
- Groninger and Co. GmbH
- Maquinaria Industrial Dara SL
- Nipro PharmaPackaging
- SCHOTT AG
- SGD Pharma
- Stevanato Group
- Syntegon Technology GmbH
- Optima Packaging Group Gmbh
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Fill Finish Manufacturing Market– By Product
1.3.2 Asia Pacific Fill Finish Manufacturing Market– By End User
1.3.3 Asia Pacific Fill Finish Manufacturing Market– By Country
2. Asia Pacific Fill Finish Manufacturing Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Fill Finish Manufacturing Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Fill Finish Manufacturing Market– Industry Dynamics
5.1 Market Drivers
5.1.1 Up-raising Adoption of Prefilled Syringes for Parenteral Administration
5.1.2 Thriving Demand for Biologics
5.2 Market Restraints
5.2.1 Raising Competition in Biopharmaceutical Contract Manufacturing Industry
5.3 Market Opportunities
5.3.1 Affordable Business Costs in Emerging Markets
5.4 Future Trends
5.4.1 Single-Usable Systems for Aseptic Fill Finish
5.5 Impact Analysis
6. Asia Pacific Fill Finish Manufacturing – Market Analysis
6.1 Asia Pacific Fill Finish Manufacturing Market Revenue Forecast and Analysis
7. Asia Pacific Fill Finish Manufacturing Market Analysis– by Product
7.1 Overview
7.2 Asia Pacific Fill Finish Manufacturing Market Share, by Product, 2019 & 2027 (%)
7.3 Consumables
7.3.1 Overview
7.3.2 Consumables Market Revenue and Forecasts to 2027 (US$ Million)
7.3.2.1 Prefilled Syringes
7.3.2.1.1 Overview
7.3.2.1.2 Prefilled Syringes: Fill Finish Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.3.2.2 Vials
7.3.2.2.1 Overview
7.3.2.2.2 Vials: Fill Finish Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.3.2.3 Cartridges
7.3.2.3.1 Overview
7.3.2.3.2 Cartridges: Fill Finish Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.3.2.4 Other Consumables
7.3.2.4.1 Overview
7.3.2.4.2 Other Consumables: Fill Finish Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecasts to 2027 (US$ Million)
8. Asia Pacific Fill Finish Manufacturing Market Analysis– by End-User
8.1 Overview
8.2 Asia Pacific Fill Finish Manufacturing Market Share, by End-User, 2019 & 2027 (%)
8.3 Biopharmaceutical Companies
8.3.1 Overview
8.3.2 Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Contract Manufacturing Organizations
8.4.1 Overview
8.4.2 Contract Manufacturing Organizations Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. Asia Pacific Fill Finish Manufacturing Market – Country Analysis
9.1 Overview
9.1.1 Asia Pacific: Fill Finish Manufacturing Market, by Country, 2019 & 2027 (%)
9.1.2 China: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.1 China: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.2 China: Fill Finish Manufacturing Market, by Product, 2018–2027 (USD Million)
9.1.2.2.1 China: Fill Finish Manufacturing Market, by Consumables, 2018–2027 (USD Million)
9.1.2.3 China: Fill Finish Manufacturing Market, by End-User, 2018–2027 (USD Million)
9.1.3 Japan: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.1 Japan: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 Japan: Fill Finish Manufacturing Market, by Product, 2018–2027 (USD Million)
9.1.3.2.1 Japan : Fill Finish Manufacturing Market, by Consumables, 2018–2027 (USD Million)
9.1.3.3 Japan: Fill Finish Manufacturing Market, by End-User, 2018–2027 (USD Million)
9.1.4 India: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.1 India: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.2 India: Fill Finish Manufacturing Market, by Product, 2018–2027 (USD Million)
9.1.4.2.1 India: Fill Finish Manufacturing Market, by Consumables, 2018–2027 (USD Million)
9.1.4.3 India: Fill Finish Manufacturing Market, by End-User, 2018–2027 (USD Million)
9.1.5 South Korea: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1 South Korea: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2 South Korea: Fill Finish Manufacturing Market, by Product, 2018–2027 (USD Million)
9.1.5.2.1 South Korea : Fill Finish Manufacturing Market, by Consumables, 2018–2027 (USD Million)
9.1.5.3 South Korea: Fill Finish Manufacturing Market, by End-User, 2018–2027 (USD Million)
9.1.6 Australia: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Australia: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Australia: Fill Finish Manufacturing Market, by Product, 2018–2027 (USD Million)
9.1.6.2.1 Australia : Fill Finish Manufacturing Market, by Consumables, 2018–2027 (USD Million)
9.1.6.3 Australia: Fill Finish Manufacturing Market, by End-User, 2018–2027 (USD Million)
9.1.7 Rest of Asia Pacific: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Rest of Asia Pacific: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Rest of Asia Pacific: Fill Finish Manufacturing Market, by Product, 2018–2027 (USD Million)
9.1.7.2.1 Rest of Asia Pacific: Fill Finish Manufacturing Market, by Consumables, 2018–2027 (USD Million)
9.1.7.3 Rest of Asia Pacific: Fill Finish Manufacturing Market, by End-User, 2018–2027 (USD Million)
10. Asia Pacific Fill Finish Manufacturing Market – Impact Of COVID-19
10.1 Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 BD
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 West Pharmaceutical Services, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Gerresheimer AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 I.M.A. Industria Macchine Automatiche S.P.A.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Optima Packaging Group Gmbh
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bausch+Strobel
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Groninger and Co. GmbH
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Maquinaria Industrial Dara SL
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Nipro PharmaPackaging
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 SCHOTT AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 SGD Pharma
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Stevanato Group SpA
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Syntegon Technology GmbH (Bosch Packaging Technology)
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Fill Finish Manufacturing Market –Revenue and Forecast to 2027 (US$ Million)
Table 2. China Fill Finish Manufacturing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 3. China Fill Finish Manufacturing Market, by Consumables – Revenue and Forecast to 2027 (USD Million)
Table 4. China Fill Finish Manufacturing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 5. Japan Fill Finish Manufacturing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. Japan Fill Finish Manufacturing Market, by Consumables – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan Fill Finish Manufacturing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 8. India Fill Finish Manufacturing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 9. India Fill Finish Manufacturing Market, by Consumables – Revenue and Forecast to 2027 (USD Million)
Table 10. India Fill Finish Manufacturing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 11. South Korea Fill Finish Manufacturing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 12. South Korea Fill Finish Manufacturing Market, by Consumables – Revenue and Forecast to 2027 (USD Million)
Table 13. South Korea Fill Finish Manufacturing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 14. Australia Fill Finish Manufacturing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 15. Australia Fill Finish Manufacturing Market, by Consumables – Revenue and Forecast to 2027 (USD Million)
Table 16. Australia Fill Finish Manufacturing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 17. Rest of Asia Pacific Fill Finish Manufacturing Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Rest of Asia Pacific Fill Finish Manufacturing Market, by Consumables – Revenue and Forecast to 2027 (USD Million)
Table 19. Rest of Asia Pacific Fill Finish Manufacturing Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, Fill Finish Manufacturing Market
LIST OF FIGURES
Figure 1. Asia Pacific Fill Finish Manufacturing Market Segmentation
Figure 2. Asia Pacific Fill Finish Manufacturing Segmentation, By Country
Figure 3. Asia Pacific Fill Finish Manufacturing Market Overview
Figure 4. Consumables Segment Held Largest Share of Asia Pacific Fill Finish Manufacturing Market
Figure 5. India to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific Fill Finish Manufacturing Market, Industry Landscape
Figure 7. Asia Pacific: PEST Analysis
Figure 8. Asia Pacific Fill Finish Manufacturing Market Impact Analysis of Driver and Restraints
Figure 9. Asia Pacific Fill Finish Manufacturing Market– Revenue Forecast and Analysis – 2019- 2027
Figure 10. Asia Pacific Fill Finish Manufacturing Market Share, by Product, 2019 & 2027 (%)
Figure 11. Consumables Market Revenue and Forecasts to 2027 (US$ Million)
Figure 12. Prefilled Syringes: Fill Finish Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Vials: Fill Finish Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. Cartridges: Fill Finish Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 15. Other Consumables: Fill Finish Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 16. Instruments Market Revenue and Forecasts to 2027 (US$ Million)
Figure 17. Asia Pacific Fill Finish Manufacturing Market Share, by End-User, 2019 & 2027 (%)
Figure 18. Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Million)
Figure 19. Contract Manufacturing Organizations Market Revenue and Forecasts to 2027 (US$ Million)
Figure 20. Others Market Revenue and Forecasts to 2027 (US$ Million)
Figure 21. China: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 22. Japan: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. India: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. South Korea: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. Australia: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Rest of Asia Pacific: Fill Finish Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
- Becton, Dickinson and Company (BD)
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
- I.M.A. Industria Macchine Automatiche S.P.A.
- Bausch+Strobel
- Groninger and Co. GmbH
- Maquinaria Industrial Dara SL
- Nipro PharmaPackaging
- SCHOTT AG
- SGD Pharma
- Stevanato Group
- Syntegon Technology GmbH
- Optima Packaging Group Gmbh
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific fill finish manufacturing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific fill finish manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the fill finish manufacturing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution